Princeton, NJ, USA, Nov 2, 2020

Yesterday Global Clinical Trials, LLC announced the launch of full-service clinical operations in Georgia by opening a new office in Tbilisi. Having successfully conducted clinical trials there, we are now pleased to announce this new corporate milestone:

“Speaking from our team’s hands-on experience, this country has the potential to offer high-quality resources and competitive enrollment rates in many indications. We are excited to broaden our geographic coverage by adding Georgia to our map of operations, and to start offering it to our clients” — GCT CEO, Dr. Eugene Selivra.

Shota Jibuti, MD is appointed the Managing Director at GCT Georgia. Before entering clinical research, he worked in the Pharmaceutical Activity department of the Ministry of Health of Georgia for over 6 years. He served as an expert, accountable for scientific-technical (pharmacological) and administrative expertise of pharmaceutical products, intended for national registration procedure in Georgia. In addition, he is the author of numerous scientific articles. Later, working at several global CROs, he gained experience in ophthalmology, cardiology, oncology, urology, CNS and gastro-intestinal diseases.

“I am incredibly excited and honored to lead GCT team in Georgia. I am extremely grateful for the opportunity to become a member of the hard-working GCT team driven to deliver an outstanding service and exceeding expectations of our clients within the clinical trials in Georgia, as well as globally.”

Georgia has a population of 3.75 million people and is located at the crossroads of Western Asia and Eastern Europe on the coast of the Black Sea. Georgia has become an attractive region for clinical trials due to the recent development of the country’s Healthcare System, as well as one of the shortest CTA review timelines within Europe.

In the last 5 years, Georgia has focused on reduction of disease burden and mortality. Currently, there are around 300 clinical centers and hospitals, most of which are located in Tbilisi. In total, Georgia has more than 16 000 hospital beds.

Many local and global companies conduct clinical research in Georgia due to numerous advantages the country has to offer:

  • Full compliance with the ICH — GCP
  • Clear regulatory requirements and a simplified process of documents submission
  • Single license for import and export of the study drug
  • Highest quality of data inspected and accepted by EMA and FDA
  • Quick Start-up. It takes only 2 months to initiate a study
  • Qualified Medical and clinical centers with experience in clinical studies
  • Highly motivated investigators, site teams and patients
  • Recognized International standards for disease treatment and prevention